|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���ǻ�֢ |
|
���� |
|
�Ŵ� |
| ��������������� | |
|
���������� |
|
��ά����У |
| PubMed | |
|
Article by ���������� |
|
Article by ��ά����У |
���ǻ�֢�IJ����Ŵ�ѧ�о���չ
����������1, ��ά����У2
1. �й�ҽѧ��ѧԺƤ�����о���;
2. �й�Э��ҽ�ƴ�ѧƤ�����о���
���ǻ�֢ͨ������֯�����Ͼ���������,�����ٴ�������ȴ���ֶ���,�ڷ�������������,������ȷ�����͵�ʵ�ʷ����ʡ�Ŀǰ��Ȼ��������������Ч����,���ǽ������ڲ�����,�������Ŵ�ѧ�������˽�������о�,Ϊ�������������ṩ��һ�������ۻ�����
1. �й�ҽѧ��ѧԺƤ�����о���;
2. �й�Э��ҽ�ƴ�ѧƤ�����о���
1. �й�ҽѧ��ѧԺƤ�����о���;
2. �й�Э��ҽ�ƴ�ѧƤ�����о���
[2] Matsushita S,Kanekura T,Kanzaki T.A case of disseminated superficialactinic porokeratosis subsequent to renal transplantation.J Dermatol,1997,24(2):110-112.
[3] Romani J,Pujol RM,Casanova JM,et al.Disseminated superficial poro-keratosis developing after electron-beam total skin irradiation for mycosisfungoides.Clin Exp Dematot.1996,21 (4):310-312.
[4] Park BS.Moon SE,Kim JA.Disseminated superficial porokeratosis in apatient with chronic liver disease.J Dermatol,1997,24(7):485-487.
[5] Rodriguez EA,Jakubowicz S,Chinchilla DA,et al.Porokeratosis of Mibelliand HIV-infection.Int J Dematol,1996,35(6):402-404.
[6] Dover JS,Phillips TJ,Bums DA,et al.Disseminated superficial actinic porokeratosis.coexistence with other porokeratotic variants.Arch Dermatol.1986,122(8):887-889.
[7] Dippel E,Haas N,Czametzki BM.Porokeratosis of mibelli associated with active chronic hepatitis and vitiligo.Acta Derm Venereol (Stockh),1994,74(6):463-464.
[8] Tsambaos D,Spiliopoulos T.Disseminated superficial porokeratosis:com plete remission subsequent to discontinuation of immuosuppression.J.AmAcad Dermatol,1993.28(4):651-652.
[9] Xia JH,Yang YF,Deng H,et al.Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1.J InvestDermatol.2000,114(6):1071-1074.
[10] Happle R.Cancer proneness of linear porokeratosis may be explained by allelic loss.Dermatolog.,1997.195(1):20-25.
[11] McNutt NS.Saenz-Santamaria C,Volkenandt M,et al.Abnomalities of p53 protein expression in cutaneous disorders.Arch Dermatol,1994,1302):225-232.
[12] Nelson C,CowlperS,Morgan M.p53,mdm-2,and p21 waf-l in the poro keratoses..Am J Dermatopathol,1999,21 (5):420-425.
[13] Magee JW,McCalmont TH,LeBoit PE,et al.Overexpression of p53 tumor suppressor protein in porokeratosis.Arch Dermatol,1994,130 (2):187-190.
[14] Ninomiya Y,Urano Y,Yoshimoto K,et al.p53 gene mutation analysis inporokeratosis and porokeratosis-associated squamous cell carcinoma.J Der-matol Sci,1997,14(3):173-178.
[15] Sakuntabhai A,Ruiz-Perez V,Carter S,et al.Mutations in ATP2A2,en-coding a Ca2 + pump,cause Darier Disease.Nat Genet,1999,21(3):271-277.
[16] Ringpfeil F,Raus A.DiGiovanna JJ,et al.Darier disease-novel mutationsin ATP2A2 and genotype-phenotype correlation.Fxp Dermatol,2001,10(1):19-27.
[17] Richard G,Smith LE,Bailey RA,et al.Mutations in the human connexingene GJB3 cause erythrokeratodema varialilis.Nat Genet,1998,20(4):366-369.
[18] Happle R.A rule conceming the segmental manifestation of autosomal dom inant skin disorders.Arch Dermatol,1997,133(12):1505-1509.
[19] Freyschmidt-Paul P,Hoffmann R,Konig A,et al.Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis:report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders.J Am Acad Dermatol,1999,41 (4):644-647.
[20] Bencini PL,Tarantino A,Grimalt R,et al.Porokeratosis and immunosuppression.Br J Dermatol,1995,132(1):74-78.